Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ATF2 |
| Upstream (Parents) |
|---|
| (<<) CREB1 → ATF2 |
| (<<) SP1 → ATF2 |
| (<<) NFYC → ATF2 |
| (<<) RXRB → ATF2 |
| (<<) HMGB1 → ATF2 |
| (<<) HSF2 → ATF2 |
| (<<) MAX → ATF2 |
| (<<) STAT2 → ATF2 |
| Downstream (Children) |
|---|
| ATF2 → EHF (>>) |
| ATF2 → TP53 (>>) |
| ATF2 → IRF6 (>>) |
| ATF2 → CTNNB1 (>>) |
| ATF2 → ZNF323 (>>) |
| ATF2 → TEAD2 (>>) |
| ATF2 → ZNF268 (>>) |
| ATF2 → GTF2I (>>) |
| ATF2 → STAT3 (>>) |
| ATF2 → RFXAP (>>) |
| ATF2 → ARNTL (>>) |
| ATF2 → GABPA (>>) |
